• 1
    Huang Y, Huang W, Long S, et al. Analysis of 1466 endometrial carcinomas in inpatients in Guangxi Zhuang Autonomous region: a 20 years' analysis [in Chinese]. Acad J Sec Mil Med Univ 2007; 28: 6814.
  • 2
    Bjørge T, Stocks T, Lukanova A, et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2010; 171: 892902.
  • 3
    Zhang Y, Liu Z, Yu X, et al. The association between metabolic abnormality and endometrial cancer: a large case-control study in China. Gynecol Oncol 2010; 117: 416.
  • 4
    Cust AE, Kaaks R, Friedenreich C, et al. Metabolic syndrome, plasma lipid, lipoprotein and glucose levels, and endometrial cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC). Endocr Relat Cancer 2007; 14: 75567.
  • 5
    Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002; 11: 153143.
  • 6
    Potischman N, Hoover RN, Brinton LA, et al. Case-control study of endogenous steroid hormones and endometrial cancer. J Natl Cancer Inst 1996; 88: 112735.
  • 7
    Sandhu MS, Dunger DB, Giovannucci EL. Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 2002, 94: 97280.
  • 8
    Jenab M, Riboli E, Cleveland RJ, et al. Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2007; 121: 36876.
  • 9
    Gunter MJ, Hoover DR, Yu H, et al. Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 2009; 101: 4860.
  • 10
    Stolzenberg-Solomon RZ, Graubard BI, Chari S, et al. Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers. JAMA 2005; 294: 28728.
  • 11
    Gunter MJ, Hoover DR, Yu H, et al. A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 9219.
  • 12
    Cust AE, Allen NE, Rinaldi S, et al. Serum levels of C-peptide, IGFBP-1 and IGFBP-2 and endometrial cancer risk; results from the European prospective investigation into cancer and nutrition. Int J Cancer 2007; 120: 265664.
  • 13
    Lukanova A, Zeleniuch-Jacquotte A, Lundin E, et al. Prediagnostic levels of C-peptide, IGF-I, IGFBP -1, -2 and -3 and risk of endometrial cancer. Int J Cancer 2004; 108: 2628.
  • 14
    Weiderpass E, Brismar K, Bellocco R, et al. Serum levels of insulin-like growth factor-I, IGF-binding protein 1 and 3, and insulin and endometrial cancer risk. Br J Cancer 2003; 89: 1697704.
  • 15
    Troisi R, Potischman N, Hoover RN, et al. Insulin and endometrial cancer. Am J Epidemiol 1997; 146: 47682.
  • 16
    Hwa V, Oh Y, Rosenfeld RG. The insulin-like growth factor-binding protein (IGFBP) superfamily. Endocr Rev 1999; 20: 76187.
  • 17
    Ruan W, Lai M. Insulin-like growth factor binding protein: a possible marker for the metabolic syndrome? Acta Diabetol 2010; 47: 514.
  • 18
    López-Bermejo A, Khosravi J, Fernández-Real JM, et al. Insulin resistance is associated with increased serum concentration of IGF-binding protein-related protein 1 (IGFBP-rP1/MAC25). Diabetes 2006; 55: 23339.
  • 19
    Oh JC, Wu W, Tortolero-Luna G, et al. Increased plasma levels of insulin-like growth factor 2 and insulin-like growth factor binding protein 3 are associated with endometrial cancer risk. Cancer Epidemiol Biomarkers Prev 2004; 13: 74852.
  • 20
    Lacey JV, Jr, Potischman N, Madigan MP, et al. Insulin-like growth factors, insulin-like growth factor-binding proteins, and endometrial cancer in postmenopausal women: results from a U.S. case-control study. Cancer Epidemiol Biomarkers Prev 2004; 13: 60712.
  • 21
    de Onis M, Habicht JP. Anthropometric reference data for international use: recommendations from a World Health Organization Expert Committee. Am J Clin Nutr 1996; 64: 6508.
  • 22
    National Measures Dyslipidemia Control Group. Prevention and treatment recommendations for dyslipidemia [in Chinese]. Chin J Cardiovasc Dis 1997; 25: 16975.
  • 23
    Forney JP, Milewich L, Chen GT, et al. Aromatization of androstenedione to estrone by human adipose tissue in vitro. Correlation with adipose tissue mass, age, and endometrial neoplasia. J Clin Endocrinol Metab 1981; 53: 1929.
  • 24
    Saltzman BS, Doherty JA, Hill DA, et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 2008; 167: 60714.
  • 25
    Balen A. Polycystic ovary syndrome and cancer. Hum Reprod Update 2001; 7: 5225.
  • 26
    Nagamani M, Stuart CA. Specific binding and growth-promoting activity of insulin in endometrial cancer cells in culture. Am J Obstet Gynecol 1998; 179: 612.
  • 27
    Kang S, Song J, Kang H, et al. Insulin can block apoptosis by decreasing oxidative stress via phosphatidylinositol 3-kinase- and extracellular signal-regulated protein kinase-dependent signaling pathways in HepG2 cells. Eur J Endocrinol 2003; 148: 14755.
  • 28
    Sowers M, Derby C, Jannausch ML, et al. Insulin resistance, hemostatic factors, and hormone interactions in pre- and perimenopausal women: SWAN. J Clin Endocrinol Metab 2003; 88: 490410.
  • 29
    Shao J, Yu L, Shen X, et al. Waist-to-height ratio, an optimal predictor for obesity and metabolic syndrome in Chinese adults. J Nutr Health Aging 2010; 14: 7825.
  • 30
    Ruan W, Zhu S, Wang H, et al. IGFBP-rP1, a potential molecule associated with colon cancer differentiation. Mol Cancer 2010; 9: 281.
  • 31
    Ma Y, Lu B, Ruan W, et al. Tumor suppressor gene insulin-like growth factor binding protein-related protein 1 (IGFBP-rP1) induces senescence-like growth arrest in colorectal cancer cells. Exp Mol Pathol 2008; 85: 1415.
  • 32
    Wajapeyee N, Serra RW, Zhu X, et al. Oncogenic BRAF induces senescence and apoptosis through pathways mediated by the secreted protein IGFBP7. Cell 2008; 132: 36374.
  • 33
    Kutsukake M, Ishihara R, Yoshie M, et al. Involvement of insulin-like growth factor-binding protein-related protein 1 in decidualization of human endometrial stromal cells. Mol Hum Reprod 2007; 13: 73743.
  • 34
    Tamura K, Matsushita M, Endo A, et al. Effect of insulin-like growth factor-binding protein 7 on steroidogenesis in granulosa cells derived from equine chorionic gonadotropin-primed immature rat ovaries. Biol Reprod 2007; 77: 48591.